"Pneumococcal Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
Descriptor ID |
D022242
|
MeSH Number(s) |
D20.215.894.135.750.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Vaccines".
This graph shows the total number of publications written about "Pneumococcal Vaccines" by people in this website by year, and whether "Pneumococcal Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 2 | 0 | 2 |
2004 | 0 | 2 | 2 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 3 | 0 | 3 |
2009 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2012 | 3 | 0 | 3 |
2013 | 1 | 0 | 1 |
2014 | 4 | 0 | 4 |
2015 | 1 | 0 | 1 |
2016 | 5 | 0 | 5 |
2017 | 72 | 19 | 91 |
2018 | 63 | 19 | 82 |
2019 | 30 | 17 | 47 |
2020 | 1 | 6 | 7 |
2021 | 3 | 7 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Pneumococcal Vaccines" by people in Profiles.
-
Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic. Eur Respir J. 2021 10; 58(5).
-
The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Int J Infect Dis. 2021 Oct; 111:196-203.
-
DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing. Clin Pharmacol Ther. 2021 12; 110(6):1537-1546.
-
The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan. Hum Vaccin Immunother. 2021 Nov 02; 17(11):4673-4674.
-
[Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en PrevenciĆ³n Group]. Semergen. 2021 Sep; 47(6):411-425.
-
The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends. Int J Environ Res Public Health. 2021 07 24; 18(15).
-
Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2021 07 20; 7:CD013706.
-
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis. Vaccine. 2021 07 13; 39(31):4278-4282.
-
Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations. Hum Vaccin Immunother. 2021 10 03; 17(10):3472-3473.
-
Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution? Vaccine. 2021 06 11; 39(26):3467-3472.